Although impairment or decreased expression of DDAH2 has been reported in several diseases such as chronic kidney disease, pulmonary hypertension, and cardiovascular disease [18–22], the association of DDAH2 with malignancy has received less attention. This evidence concerns the gene DDAH2 and pulmonary arterial hypertension.